Study of professional practices among rheumatologists in Burgundy: initial corticotherapy  in polymyalgia rheumatica

Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • مؤلف : Paul Ornetti & Caroline Guillibert-Karras & Jean-François Garrot & Florence Gros & Nathalie Gérard & Laurence Julien & Françoise Pascaud & Thierry Pee
  • چاپ و سال / کشور: 2011

Description

To study the initial dose of corticoids prescribed by rheumatologists in the Côte d'Or, a French department of Burgundy, in the treatment of polymyalgia rheumatica (PMR), the clinical and biological data of patients who consulted rheumatologists of the Côte d'Or between March 2006 and December 2008 for PMR were collected. The statistical analyses concerned the initially prescribed dose of prednisone: the median, mean, and standard deviation were calculated cumulatively and then for individual rheumatologists; the Mann–Whitney test was used to compare the mean initial doses prescribed with regard to (a) the main practice of the practitioner (private-practice or hospital rheumatologist), (b) the presence of clinical signs of severity, (c) severity of the inflammatory syndrome, and (d) the presence of clinical relapse with the decrease in corticoids. Ninety-nine patients were included (age=72± 8.6 years, 59% women). The mean dose of prednisone prescribed was 27.4±12.4 mg/day. Considerable inter- and intra-individual variabilities in the doses prescribed were noted. There was no significant difference concerning the dose prescribed according to the clinical severity or the type of practice. However, the dose was significantly higher (34.3±14.7 vs. 25.5±11.1 mg/day) in patients with a high sedimentation rate. Clinical relapse was not statistically linked to the initial dose of corticoids. This evaluation of professional practices among French rheumatologists shows that the initial dose of prednisone prescribed in PMR varies considerably and is higher than the dose currently recommended in the literature (15 mg/day).
Clin Rheumatol (2011) 30:51–56 Received: 23 February 2010 / Revised: 13 October 2010 / Accepted: 31 October 2010 / Published online: 18 November 2010
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری